In prostate cancer, STEAP2 expression was associated with ERK activity; phosphorylation of ERK was increased on ectopic expression of STEAP2 and was strongly downregulated in STEAP2 knockdown cells15. Here, STEAP2 is linked to prostate carcinoma.